These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Identification of potential phytochemicals from Khan J; Sakib SA; Mahmud S; Khan Z; Islam MN; Sakib MA; Emran TB; Simal-Gandara J J Biomol Struct Dyn; 2022; 40(21):10741-10752. PubMed ID: 34278965 [TBL] [Abstract][Full Text] [Related]
24. Phytoconstituents from Moringa oleifera fruits target ACE2 and open spike glycoprotein to combat SARS-CoV-2: An integrative phytochemical and computational approach. Siddiqui S; Ahmad R; Alaidarous M; Zia Q; Ahmad Mir S; Alshehri B; Srivastava A; Trivedi A J Food Biochem; 2022 May; 46(5):e14062. PubMed ID: 35043973 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of the dual effects of antiviral drugs on SARS-CoV-2 receptors and the ACE2 receptor using structure-based virtual screening and molecular dynamics simulation. Jahantigh HR; Ahmadi N; Shahbazi B; Lovreglio P; Habibi M; Stufano A; Gouklani H; Ahmadi K J Biomol Struct Dyn; 2023; 41(13):6051-6073. PubMed ID: 35876061 [TBL] [Abstract][Full Text] [Related]
26. Identification of potential plant-based inhibitor against viral proteases of SARS-CoV-2 through molecular docking, MM-PBSA binding energy calculations and molecular dynamics simulation. Gogoi B; Chowdhury P; Goswami N; Gogoi N; Naiya T; Chetia P; Mahanta S; Chetia D; Tanti B; Borah P; Handique PJ Mol Divers; 2021 Aug; 25(3):1963-1977. PubMed ID: 33856591 [TBL] [Abstract][Full Text] [Related]
27. Computational Evidences of Phytochemical Mediated Disruption of PLpro Driven Replication of SARS-CoV-2: A Therapeutic Approach against COVID-19. Balkrishna A; Mittal R; Arya V Curr Pharm Biotechnol; 2021; 22(10):1350-1359. PubMed ID: 33176643 [TBL] [Abstract][Full Text] [Related]
28. Interaction of Bioactive Compounds of Moringa oleifera Leaves with SARS-CoV-2 Proteins to Combat COVID-19 Pathogenesis: a Phytochemical and In Silico Analysis. Siddiqui S; Upadhyay S; Ahmad R; Barkat MA; Jamal A; Alothaim AS; Hassan MZ; Rahman MA; Arshad M; Ahamad T; Khan MF; Shankar H; Ali M; Kaleem S; Ahmad J Appl Biochem Biotechnol; 2022 Dec; 194(12):5918-5944. PubMed ID: 35838886 [TBL] [Abstract][Full Text] [Related]
29. Molecular docking, validation, dynamics simulations, and pharmacokinetic prediction of natural compounds against the SARS-CoV-2 main-protease. C S; S DK; Ragunathan V; Tiwari P; A S; P BD J Biomol Struct Dyn; 2022 Feb; 40(2):585-611. PubMed ID: 32897178 [TBL] [Abstract][Full Text] [Related]
30. Identification of potent food constituents as SARS-CoV-2 papain-like protease modulators through advanced pharmacoinformatics approaches. Bhowmick S; Saha A; AlFaris NA; ALTamimi JZ; ALOthman ZA; Aldayel TS; Wabaidur SM; Islam MA J Mol Graph Model; 2022 Mar; 111():108113. PubMed ID: 34959151 [TBL] [Abstract][Full Text] [Related]
34. Structure-based virtual screening, molecular dynamics and binding affinity calculations of some potential phytocompounds against SARS-CoV-2. Naik SR; Bharadwaj P; Dingelstad N; Kalyaanamoorthy S; Mandal SC; Ganesan A; Chattopadhyay D; Palit P J Biomol Struct Dyn; 2022 Sep; 40(15):6921-6938. PubMed ID: 33682632 [TBL] [Abstract][Full Text] [Related]
35. In-Silico approach for identification of effective and stable inhibitors for COVID-19 main protease (M Das P; Majumder R; Mandal M; Basak P J Biomol Struct Dyn; 2021 Oct; 39(16):6265-6280. PubMed ID: 32705952 [TBL] [Abstract][Full Text] [Related]
36. Comprehensive Virtual Screening of the Antiviral Potentialities of Marine Polycyclic Guanidine Alkaloids against SARS-CoV-2 (COVID-19). El-Demerdash A; Metwaly AM; Hassan A; Abd El-Aziz TM; Elkaeed EB; Eissa IH; Arafa RK; Stockand JD Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33808721 [TBL] [Abstract][Full Text] [Related]
37. Screening of phytochemicals as potent inhibitor of 3-chymotrypsin and papain-like proteases of SARS-CoV2: an in silico approach to combat COVID-19. Swargiary A; Mahmud S; Saleh MA J Biomol Struct Dyn; 2022 Mar; 40(5):2067-2081. PubMed ID: 33089730 [TBL] [Abstract][Full Text] [Related]
38. Sterenin M as a potential inhibitor of SARS-CoV-2 main protease identified from MeFSAT database using molecular docking, molecular dynamics simulation and binding free energy calculation. Prajapati J; Patel R; Goswami D; Saraf M; Rawal RM Comput Biol Med; 2021 Aug; 135():104568. PubMed ID: 34174757 [TBL] [Abstract][Full Text] [Related]
39. A computational essential dynamics approach to investigate structural influences of ligand binding on Papain like protease from SARS-CoV-2. Singh E; Jha RK; Khan RJ; Kumar A; Jain M; Muthukumaran J; Singh AK Comput Biol Chem; 2022 Aug; 99():107721. PubMed ID: 35835027 [TBL] [Abstract][Full Text] [Related]
40. Investigation of the interactions of HSA and SARS-CoV-2 papain-like protease against eugenol for novel COVID-19 drug discovery: spectroscopic and insilico study. Naz F; Khan I; Baammi S; Islam A J Biomol Struct Dyn; 2023 Nov; 41(19):10161-10170. PubMed ID: 36636828 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]